Compensatory changes in energy balance during dapagliflozin treatment in type 2 diabetes mellitus: a randomised double-blind, placebo-controlled, cross-over trial (ENERGIZE)—study protocol

INTRODUCTION: Sodium glucose cotransporter 2 (SGLT2) inhibitors are effective blood-glucose-lowering medications with beneficial effects on body weight in patients with type 2 diabetes mellitus (T2DM). However, observed weight loss is less than that predicted from quantified glycosuria, suggesting a...

Descripción completa

Detalles Bibliográficos
Autores principales: Rajeev, Surya Panicker, Sprung, Victoria S, Roberts, Carl, Harrold, Jo A, Halford, Jason C G, Stancak, Andrej, Boyland, Emma J, Kemp, Graham J, Cuthbertson, Daniel J, Wilding, John P H
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BMJ Publishing Group 2017
Materias:
Diabetes and Endocrinology
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5278268/
https://www.ncbi.nlm.nih.gov/pubmed/28132008
http://dx.doi.org/10.1136/bmjopen-2016-013539

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5278268/
https://www.ncbi.nlm.nih.gov/pubmed/28132008
http://dx.doi.org/10.1136/bmjopen-2016-013539

Ejemplares similares